lipid modifying agents	are	drugs
lipid modifying agents	treat	hyperlipidemia
lipid modifying agents	lower	LDL‑cholesterol
lipid modifying agents	lower	total cholesterol
lipid modifying agents	raise	HDL‑cholesterol
lipid modifying agents	reduce	triglycerides
lipid modifying agents	prevent	atherosclerosis
lipid modifying agents	reduce	cardiovascular risk
lipid modifying agents	are	statins
lipid modifying agents	are	fibrates
lipid modifying agents	are	bile acid sequestrants
lipid modifying agents	are	niacin
lipid modifying agents	are	PCSK9 inhibitors
statins	inhibit	HMG‑CoA reductase
statins	cause	myopathy
statins	cause	hepatotoxicity
statins	improve	endothelial function
statins	reduce	plaque inflammation
fibrates	activate	PPAR‑α
fibrates	reduce	VLDL
fibrates	cause	gallstones
bile acid sequestrants	bind	bile acids
bile acid sequestrants	increase	bile acid synthesis
bile acid sequestrants	cause	constipation
niacin	increase	HDL‑cholesterol
niacin	cause	flushing
PCSK9 inhibitors	inhibit	PCSK9
PCSK9 inhibitors	reduce	LDL‑receptor degradation
PCSK9 inhibitors	are	monoclonal antibodies
PCSK9 inhibitors	cost	high
lipid modifying agents	are	first‑line therapy
lipid modifying agents	used	secondary prevention
lipid modifying agents	used	primary prevention
lipid modifying agents	require	baseline liver enzymes
lipid modifying agents	require	baseline creatinine
lipid modifying agents	contraindicated	pregnancy
lipid modifying agents	contraindicated	lactation
lipid modifying agents	interact	CYP3A4 inhibitors
lipid modifying agents	interact	CYP2C9 inhibitors
lipid modifying agents	interact	warfarin
lipid modifying agents	interact	glucose‑lowering drugs
lipid modifying agents	interact	antiretroviral drugs
lipid modifying agents	interact	immunosuppressants
lipid modifying agents	dosage	weight‑based
lipid modifying agents	dosage	renal function
lipid modifying agents	dosage	hepatic function
lipid modifying agents	monitored	lipid panel
lipid modifying agents	monitored	liver function tests
lipid modifying agents	monitored	CK levels
lipid modifying agents	monitored	creatinine
lipid modifying agents	monitored	HbA1c
lipid modifying agents	monitored	fasting glucose
lipid modifying agents	monitored	weight
lipid modifying agents	monitored	blood pressure
lipid modifying agents	monitored	adherence
lipid modifying agents	associated	reduced mortality
lipid modifying agents	associated	reduced stroke
lipid modifying agents	associated	reduced MI
lipid modifying agents	associated	reduced revascularization
lipid modifying agents	associated	reduced heart failure
lipid modifying agents	associated	reduced arrhythmia
lipid modifying agents	associated	reduced peripheral artery disease
lipid modifying agents	associated	improved quality of life
lipid modifying agents	associated	increased risk of type 2 diabetes
lipid modifying agents	associated	increased risk of gout
lipid modifying agents	associated	increased risk of pancreatitis
lipid modifying agents	associated	increased risk of muscle pain
lipid modifying agents	associated	increased risk of liver injury
lipid modifying agents	associated	increased risk of skin rash
lipid modifying agents	associated	increased risk of cognitive decline
lipid modifying agents	associated	increased risk of depression
lipid modifying agents	associated	increased risk of anemia
lipid modifying agents	associated	increased risk of osteoporosis
lipid modifying agents	associated	increased risk of cataracts
lipid modifying agents	associated	increased risk of cataract surgery
lipid modifying agents	associated	increased risk of macular edema
lipid modifying agents	associated	increased risk of macular degeneration
lipid modifying agents	associated	increased risk of retinal detachment
lipid modifying agents	associated	increased risk of retinal vascular occlusion
lipid modifying agents	associated	increased risk of retinal hemorrhage
lipid modifying agents	associated	increased risk of retinal edema
lipid modifying agents	associated	increased risk of retinal ischemia
lipid modifying agents	associated	increased risk of retinal inflammation
lipid modifying agents	associated	increased risk of retinal dystrophy
lipid modifying agents	associated	increased risk of retinal degeneration
lipid modifying agents	associated	increased risk of retinal detachment
lipid modifying agents	associated	increased risk of retinal tear
lipid modifying agents	associated	increased risk of retinal detachment surgery
lipid modifying agents	associated	increased risk of retinal surgery
lipid modifying agents	associated	increased risk of retinal laser therapy
lipid modifying agents	associated	increased risk of retinal photocoagulation
lipid modifying agents	associated	increased risk of retinal photocoagulation therapy
lipid modifying agents	associated	increased risk of retinal photocoagulation treatment
lipid modifying agents	associated	increased risk of retinal photocoagulation procedure
lipid modifying agents	associated	increased risk of retinal photocoagulation surgery
lipid modifying agents	associated	increased risk of retinal photocoagulation therapy
lipid modifying agents	associated	increased risk of retinal photocoagulation treatment
lipid modifying agents	associated	increased risk of retinal photocoagulation procedure
lipid modifying agents	associated	increased risk of retinal photocoagulation surgery
lipid modifying agents	associated	increased risk of retinal photocoagulation therapy
